Aveanna Healthcare (NASDAQ:AVAH) Major Shareholder Paul Vigano Sells 3,000,000 Shares of Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) major shareholder Paul Vigano sold 3,000,000 shares of the stock in a transaction dated Tuesday, June 30th. The shares were sold at an average price of $8.01, for a total transaction of $24,030,000.00. Following the transaction, the insider directly owned 190,130 shares of the company’s stock, valued at $1,522,941.30. This trade represents a 94.04% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Major shareholders that own more than 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

Aveanna Healthcare Trading Up 2.7%

Shares of AVAH stock opened at $9.10 on Friday. The company has a current ratio of 1.47, a quick ratio of 1.47 and a debt-to-equity ratio of 5.35. The stock has a market capitalization of $1.98 billion, a price-to-earnings ratio of 7.71, a price-to-earnings-growth ratio of 0.91 and a beta of 1.89. Aveanna Healthcare Holdings Inc. has a 12-month low of $3.73 and a 12-month high of $10.32. The stock’s 50-day moving average price is $7.31 and its 200-day moving average price is $7.56.

Aveanna Healthcare (NASDAQ:AVAH) last released its quarterly earnings data on Thursday, May 14th. The company reported $0.18 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.13 by $0.05. The business had revenue of $647.91 million for the quarter, compared to the consensus estimate of $613.22 million. Aveanna Healthcare had a return on equity of 124.68% and a net margin of 10.37%.The company’s revenue was up 15.9% on a year-over-year basis. Equities research analysts predict that Aveanna Healthcare Holdings Inc. will post 0.65 EPS for the current fiscal year.

Hedge Funds Weigh In On Aveanna Healthcare

Several large investors have recently modified their holdings of AVAH. AustralianSuper Pty Ltd purchased a new stake in Aveanna Healthcare during the 3rd quarter valued at $15,743,000. Vanguard Group Inc. boosted its stake in Aveanna Healthcare by 38.0% during the fourth quarter. Vanguard Group Inc. now owns 5,577,010 shares of the company’s stock worth $45,564,000 after buying an additional 1,535,351 shares during the period. Millennium Management LLC boosted its stake in Aveanna Healthcare by 1,007.1% during the fourth quarter. Millennium Management LLC now owns 1,114,717 shares of the company’s stock worth $9,107,000 after buying an additional 1,014,030 shares during the period. Nuveen LLC increased its position in Aveanna Healthcare by 135.9% during the fourth quarter. Nuveen LLC now owns 1,571,308 shares of the company’s stock valued at $12,838,000 after acquiring an additional 905,316 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership increased its position in Aveanna Healthcare by 451.3% during the third quarter. Arrowstreet Capital Limited Partnership now owns 959,488 shares of the company’s stock valued at $8,511,000 after acquiring an additional 785,452 shares during the last quarter. Institutional investors own 87.96% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on AVAH shares. BMO Capital Markets decreased their price target on shares of Aveanna Healthcare from $11.00 to $10.00 and set an “outperform” rating on the stock in a research note on Friday, March 20th. Raymond James Financial raised shares of Aveanna Healthcare from an “outperform” rating to a “strong-buy” rating and set a $13.00 price objective for the company in a research note on Friday, March 20th. Truist Financial boosted their target price on shares of Aveanna Healthcare from $8.00 to $9.00 and gave the stock a “hold” rating in a report on Wednesday, May 20th. Barclays decreased their target price on shares of Aveanna Healthcare from $9.50 to $9.00 and set an “overweight” rating on the stock in a research report on Monday, May 18th. Finally, Stephens raised shares of Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and increased their price target for the company from $10.00 to $11.00 in a report on Friday, May 15th. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $10.50.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.